Detalhe da pesquisa
1.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
N Engl J Med
; 387(20): 1855-1864, 2022 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36342163
2.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36779348
3.
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
Circulation
; 145(18): 1377-1386, 2022 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35369705
4.
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
Circulation
; 146(15): 1109-1119, 2022 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36031810
5.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36036760
6.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 380(4): 347-357, 2019 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-30415602
7.
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 41(12): 3005-3014, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34706556
8.
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
Circulation
; 141(15): 1227-1234, 2020 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31983236
9.
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 140(22): 1792-1801, 2019 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31597460
10.
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
N Engl J Med
; 376(18): 1713-1722, 2017 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28304224
11.
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 40(19): 1541-1550, 2019 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30624719
12.
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
Circulation
; 138(8): 756-766, 2018 08 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29626068
13.
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 134(1): 24-36, 2016 Jul 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27358434
14.
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Lancet
; 385(9984): 2288-95, 2015 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-25769361
15.
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
JAMA
; 315(15): 1591-9, 2016 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27043082
16.
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.
Eur J Prev Cardiol
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38484368
17.
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
J Clin Lipidol
; 18(2): e261-e268, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38158248
18.
Changes in diet and physical activity resulting from the Shape Up Somerville community intervention.
BMC Pediatr
; 13: 157, 2013 Oct 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24093936
19.
Decision-Making During Percutaneous Coronary Intervention Guided by Optical Coherence Tomography: Insights From the LightLab Initiative.
Circ Cardiovasc Interv
; 15(11): 872-881, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36378739
20.
Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention.
Circ Cardiovasc Interv
; 15(3): e011382, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35209731